Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. SERA
stocks logo

SERA

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Financial AI Agent
Financial AI Agent

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2026Q1
FY2026Q2
20.00K
-16.67%
-0.200
-20%
85.00K
+123.68%
-0.180
-10%
80.00K
+370.59%
-0.190
+18.75%
Estimates Revision
The market is revising No Change the revenue expectations for Sera Prognostics, Inc. (SERA) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by -10.78%.
Revenue Estimates for FY2025
No Change
down Image
0.00%
In Past 3 Month
EPS Estimates for FY2025
No Change
down Image
0.00%
In Past 3 Month
Stock Price
Go Down
down Image
-10.78%
In Past 3 Month

Valuation Metrics

The current forward P/E ratio for Sera Prognostics Inc (SERA.O) is -3.97, compared to its 5-year average forward P/E of -4.47. For a more detailed relative valuation and DCF analysis to assess Sera Prognostics Inc 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-4.47
Current PE
-3.97
Overvalued PE
-1.40
Undervalued PE
-7.55

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
-2.14
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
1.58
Undervalued EV/EBITDA
-5.86

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
219.95
Current PS
0.00
Overvalued PS
470.23
Undervalued PS
-30.33
AI Stock Picker
AI Stock Picker

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Intellectia AI SwingMax
Intellectia AI SwingMax

SERA News & Events

Events Timeline

(ET)
2025-11-24
08:07:41
Sera Prognostics Receives Acceptance for Publication of PRIME Study Findings
select
2025-05-08 (ET)
2025-05-08
16:43:28
Sera Prognostics names Lee Anderson as Chief Commercial Officer
select
2025-03-19 (ET)
2025-03-19
16:14:07
Sera Prognostics appoints Jeff Elliott to Board, two members stepping down
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
6.0
11-27NASDAQ.COM
Sera Prognostics (SERA) Receives Upgrade to Buy: Reasons Explained

  • Sera Prognostics Upgrade: Sera Prognostics, Inc. has been upgraded to a Zacks Rank #2 (Buy) due to a positive shift in earnings estimates, indicating a favorable outlook for the company's stock price.

  • Earnings Estimate Revisions: The Zacks rating system, which correlates earnings estimate revisions with stock price movements, suggests that Sera's rising estimates reflect an improvement in its underlying business, likely leading to higher stock performance.

  • Zacks Rank System: The Zacks Rank system classifies stocks based on earnings estimates, with only the top 20% receiving a "Strong Buy" or "Buy" rating, highlighting Sera's strong position among its peers.

  • AI Investment Opportunities: The article also discusses the potential for significant wealth creation in the next phase of AI development, suggesting that early investors in emerging companies may benefit from substantial gains.

[object Object]
Preview
9.0
11-24PRnewswire
Sera Announces Publication Acceptance for PRIME Study

  • PRIME Study Publication: The findings of the PRIME study, a significant research project on preterm birth, have been accepted for publication in a peer-reviewed medical journal after being presented as a late-breaking abstract at the Society for Maternal-Fetal Medicine's annual meeting.

  • Sera Prognostics Overview: Sera Prognostics, Inc. is dedicated to enhancing maternal and neonatal health through innovative pregnancy biomarker information, with its PreTRM® Test being the only validated blood-based biomarker test for predicting spontaneous preterm birth risk in asymptomatic singleton pregnancies.

[object Object]
Preview
5.0
11-21Newsfilter
Quanterix Unveils Leadership and Board Changes to Facilitate Future Growth

  • Leadership Appointments: Quanterix Corporation has appointed Garret Hampton, Ph.D., and Alan Sachs, M.D., Ph.D., to its Board of Directors, while William Donnelly has been named Executive Chair and Jeffrey Elliott as Lead Independent Director.

  • Strategic Focus: The leadership changes aim to support Quanterix's growth initiatives, including expanding its biomarker offerings and launching new diagnostic tools, particularly for Alzheimer's disease.

  • Board Composition Changes: Paul Meister and David Walt, Ph.D., are stepping down from the Board, leaving Quanterix with a total of nine board members, seven of whom are independent.

  • Future Outlook: The new board members bring extensive experience in life sciences and diagnostics, which is expected to enhance Quanterix's strategic direction and operational alignment as it integrates recent acquisitions and focuses on growth.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Sera Prognostics Inc (SERA) stock price today?

The current price of SERA is 2.98 USD — it has decreased -3.56 % in the last trading day.

arrow icon

What is Sera Prognostics Inc (SERA)'s business?

Sera Prognostics, Inc. is a women's health diagnostic company utilizing its proprietary proteomics and bioinformatics platform, and significant data resources to enhance maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. It has built a proteomics and bioinformatics platform to characterize the biology of pregnancy and to discover and validate key protein biomarkers found in blood that are accurate predictors of dynamic changes that occur during pregnancy. Its commercial product, the PreTRM test, is a validated, commercially available blood-based biomarker test to predict the risk of a premature delivery, also known as preterm birth. The PreTRM test is a non-invasive blood test given to a pregnant woman, carrying a single fetus, during weeks 18 through 20 of gestation that provides a prediction of the expectant mother’s risk of delivering spontaneously before 37 weeks’ gestation.

arrow icon

What is the price predicton of SERA Stock?

Wall Street analysts forecast SERA stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for SERA is  USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Sera Prognostics Inc (SERA)'s revenue for the last quarter?

Sera Prognostics Inc revenue for the last quarter amounts to 16.00K USD, decreased -44.83 % YoY.

arrow icon

What is Sera Prognostics Inc (SERA)'s earnings per share (EPS) for the last quarter?

Sera Prognostics Inc. EPS for the last quarter amounts to -0.16 USD, decreased -33.33 % YoY.

arrow icon

What changes have occurred in the market's expectations for Sera Prognostics Inc (SERA)'s fundamentals?

The market is revising No Change the revenue expectations for Sera Prognostics, Inc. (SERA) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by -10.78%.
arrow icon

How many employees does Sera Prognostics Inc (SERA). have?

Sera Prognostics Inc (SERA) has 63 emplpoyees as of December 05 2025.

arrow icon

What is Sera Prognostics Inc (SERA) market cap?

Today SERA has the market capitalization of 115.01M USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free